Electronic Informed Consent for Clinical Trials: Why, What and How - Webinar by GlobalCompliancePanel

MessageThis Webinar is over
Date Dec 9, 2013
Time 10:00 AM PDT
Cost $225.00
Overview: This webinar will present an exploration of trends that are leading to adoption of e-consent; options are available for e-consent, what is involved in implementing e-consent. A live demonstration of an e-consent will set the stage for implementation questions. 

Why Should You Attend : Why are you considering e-consent:
  • Lack of patient interest in trial participation
  • Need for greater patient involvement during trial
  • Need to explain complex terms and protocol
  • Need to implement remote monitoring
What concerns you the most: 
  • Reaction of the IRB
  • FDA non-acceptance of the consents
  • Patient inability to use technology
  • Lack of acceptance by clinical staff
  • Cost
  • Timelines
Areas Covered in the Session
  • Using an e-consent to assist low literacy patient populations understand your trial
  • Using e-consent to assist patients in understanding their role in a complex clinical trial.
  • Working with an IRB in the review of a e-consent
  • Understanding the cost drivers of an e-consent process
  • Features of an e-consent. Deciding what is important to your trial.
Who Will Benefit:
  • Clinical trial Innovation teams
  • VP, Clinical trials
  • Clinical Operations (VP, Senior Managers, Trial Managers)
  • IT innovation leads
  • Managers, VPs Research Portfolios
Dr. Brink co-founded ConsentSolutions, Inc. in 2006 to further the development of media-based approaches to informed consent for clinical trials. She is the CEO and President. The company grew out of Phase II SBIR NCI funding for the development of an online informed consent process for clinical trials, on which she was the PI.

NetZealous LLC,
DBA GlobalCompliancePanel 
161 Mission Falls Lane,
Suite 216, Fremont, CA 94539, USA          
USA Phone:800-447-9407
Fax: 302-288-6884


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list